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Sindbis virus glycoproteins El and E2 undergo a conformational alteration during early virus-cell interaction
at the cell surface (D. Flynn, W. J. Meyer, J. M. MacKenzie, Jr., and R. E. Johnston, J. Virol. 64:3643-3653,
1990). Certain epitopes normally internal on native virus become accessible to monoclonal antibody (MAb)
binding after attachment but before internalization of virus particles. These newly exposed epitopes, termed
transitional epitopes, may be part of functionally important domains made accessible at the surface of the
altered virus to facilitate entry into cells. Heating Sindbis virions at 51°C for a short time induced a similar,
although not identical, exposition of transitional epitopes on the El and E2 glycoproteins (W. J. Meyer, S.
Gidwitz, V. K. Ayers, R. J. Schoepp, and R. E. Johnston, J. Virol. 66:3504-3513, 1992). In the current report,
we have identified several of the transitional epitopes that become exposed as a consequence of early virus-cell
interactions. Transitional epitope MAbs that bound to rearranged, heated virions and virus-cell complexes
were used in antibody competition binding assays on heated Sindbis virions to map the spatial relationships
between native, external, neutralizing antigenic sites and newly exposed transitional epitopes. Because the
heated, rearranged particles retained their infectivity, MAbs that bound to transitional epitopes also were used
to isolate MAb neutralization escape mutants. Sequencing the glycoprotein genes of the escape mutants
identified specific El and E2 loci where mutation prevented MAb binding to transitional epitopes. One of the
transitional epitopes identified (E2 residues 200 to 202) lies in the E2 190-216 region, which harbors two major
neutralization sites, E2a and E2b, and an N-linked glycosylation site at E2 196. The glycosylation signal was
eliminated by site-directed mutagenesis of a full-length cDNA clone of the Sindbis virus genome. The absence
of a carbohydrate moiety did not expose the transitional epitopes mapped to this locus, suggesting that on native
virions, the inaccessibility of the E2 200-202 determinant was inherent in the structure of the glycoprotein
spike.
The early stages of virus infection include a number of
critical steps, each involving an interaction of the infecting
virion with an element of the cell, culminating with the
release of the viral genome in a form suitable for gene
expression. Understanding the nature of these events will
require identification and characterization of the virion
structural intermediates generated during this disassembly
process and the cellular elements which catalyze the conver-
sion of one intermediate to the next. We report here the
antigenic and topographic characterization of the initial
structural intermediate in the disassembly pathway for the
prototype alphavirus, Sindbis virus.
The genome of Sindbis virus is a positive-sense, single-
stranded RNA and is contained within a T=4 nucleocapsid
composed of capsid (C) protein subunits (9, 31, 32). The
nucleocapsid is surrounded by a host cell-derived, lipid
envelope containing two viral glycoproteins, El and E2 (19,
38). Within the envelope, El and E2 are associated as
heterodimers which in turn are assembled in groups of three
to form an icosahedral arrangement at the virus surface (15,
31, 36). The carboxy terminus of one (or both) of the
glycoproteins, probably that of E2, is thought to associate
with capsid protein subunits at the inner face of the enve-
lope, accounting for the T=4 symmetry of the glycoprotein
spikes on the exterior face. Lateral interactions between the
glycoproteins serve to stabilize the structure (2).
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In the infection of baby hamster kidney (BHK) cells,
Sindbis virions appear to be converted to a first disassembly
intermediate at the cell surface, presumably in response to
their interaction with receptor or the microenvironment at
the cell surface (8, 13). Additional structural changes may
occur at the cell surface, leading to fusion with the plasma
membrane and release of the nucleocapsid into the cyto-
plasm (1). Alternatively, the initial cell surface alterations
may precede virion endocytosis, subsequent rearrange-
ment(s) triggered by the low-pH environment of the endo-
some, fusion with the endosomal membrane, and release of
the capsid (22, 50). The final event is uncoating, removal of
the genome from the nucleocapsid, may be mediated by an
interaction of the newly released capsid with cytoplasmic
ribosomes (42, 49).
Changes in the conformation of Sindbis virus and other
alphaviruses have been detected by probing suspected struc-
tural intermediates with monoclonal antibodies (MAbs) or
proteases. Structural rearrangements in response to treat-
ment at low pH or after endocytosis have been inferred by
changes in the protease sensitivities of El and/or E2 (12, 22)
or by changes in the reactivities of MAbs raised to low-pH-
treated virions (37). Under conditions of hemagglutination or
during morphogenesis, alterations in glycoprotein conforma-
tion were detected as changes in the constellation of acces-
sible glycoprotein epitopes (40). Our laboratory has used
MAb probes to demonstrate an early conformational alter-
ation of Sindbis virions at the cell surface (13). A subset of
MAbs specific for inaccessible epitopes on glycoproteins El
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and E2 of native virus, and hence not capable of binding
intact virus in solution, nevertheless binds to virus-BHK cell
complexes at 37°C. Such newly exposed epitopes have been
termed transitional epitopes. A step early in the interaction
of the virus with the cell triggers the rearrangement in the
absence of a low-pH involvement. The alteration occurs
either before or coincident with penetration, and rearrange-
ment of a rapidly penetrating mutant is accelerated. Treat-
ment of virus-cell complexes with MAbs to a transitional
epitope retarded penetration of replication-competent viri-
ons, suggesting that the rearrangement produced an early
intermediate in a disassembly pathway leading to productive
infection.
A glycoprotein rearrangement very similar to that appar-
ent at the cell surface can be artificially induced by heating
Sindbis virions to 51°C for 5 to 10 min (28). The constellation
of accessible native and transitional epitopes displayed on
virions at the cell surface is closely approximated on heated
particles. In this study, we have used these heated virions to
determine the topographic relationships between several of
the transitional epitopes as well as between the transitional
epitopes and previously mapped neutralization sites on
glycoprotein E2. The rearranged, heated virions retain in-
fectivity and can be neutralized by the transitional epitope
MAbs (28). Therefore, we have isolated neutralization es-
cape mutants which bound reduced amounts of the selecting
transitional MAb. By sequencing the glycoprotein genes of
such mutants, the presumptive epitopes for several of the
transitional MAbs have been mapped to specific regions of
the primary amino acid sequence.
MATERIALS AND METHODS
Virus strains and cells. All virus strains were grown on
BHK cells maintained in Eagle's minimal essential medium
(GIBCO) containing 5% penicillin and streptomycin, 10%
tryptose phosphate broth (Difco), and 10% donor calf serum.
Our laboratory strain of Sindbis virus, AR339, was supplied
originally by H. R. Bose, University of Texas, Austin.
SB-RL (SB-reduced latent period) was derived from Sindbis
virus AR339 as previously described (5). TR5000 is a recom-
binant virus obtained by transfection of BHK cells with
transcripts generated in vitro from a plasmid containing Toto
1101 nucleotides 1 through 2712 and 11485 through the 3'
poly(A) tract (34) and Sindbis virus AR339 sequences from
nucleotides 2713 through 11484. The Sindbis virus AR339
nucleotides encode all of the structural proteins of TR5000.
Plasmids pTR5196 and pTR5278 were derived by site-di-
rected mutagenesis of TR5000 by the method of Kunkel et al.
(23). The pTR5196 construct has a glutamine codon (CAG)
substituted for the wild-type asparagine (AAC) at amino acid
position 196 of the E2 glycoprotein. The pTR5278 construct
has a tyrosine codon (UAC) substituted for the wild-type
histidine (CAC) at E2 position 278.
MAbs. MAbs against Sindbis virus were produced from
two separate hybridoma fusions. In the first fusion, mice
were immunized and boosted with native SB-RL. Isolation
and characterization of MAbs R6, R8, R10, and R15 have
been described previously (29). MAbs R2, R4, and R12 were
also from the first fusion and are specific for inaccessible
epitopes on the El and E2 glycoproteins of native Sindbis
virus (13). Antibody specificity was determined by radioim-
munoprecipitation as described previously (29) or with the
following modifications. Infected cells were labeled with 20
,uCi of [ 5S]methionine per ml for 10 min at 4.5 h postinfec-
tion. After overnight incubation of the labeled lysates with
MAb, 2.5 ,ul of goat anti-mouse immunoglobulins (Ig) (Sig-
ma) was added, and the mixture was incubated for 4 h at 4°C
before addition of Pansorbin (Calbiochem). Immunoprecip-
itates were washed in lysis buffer containing 1 M NaCl. In
some experiments, lysates were prepared in sodium dodecyl
sulfate (SDS)-containing buffer either with or without 1 M
NaCl. In other experiments, Affi-Gel 10 (Bio-Rad) or cyano-
gen bromide-activated Sepharose (Pharmacia), conjugated
with goat anti-mouse Ig, was used to precipitate protein-
antibody complexes. The manufacturers' suggested condi-
tions were used in both cases.
The R500 series of antibodies was generated from a
second fusion. BALB/c mice were injected intraperitoneally
and subcutaneously with 25 jig of SB-RL in Freund's
complete adjuvant. Four days later, the mice were infected
with 108 PFU of purified SB-RL by subcutaneous inocula-
tion. After 4 months, one mouse was selected and boosted
intravenously with 100 ,ug of SB-RL that had been boiled for
5 min in 0.1% SDS. The next day, the mouse was injected
intraperitoneally with 100 ,ug of SB-RL that had been boiled
in 0.36% SDS. Two days later, the mouse was sacrificed, the
spleen was removed, and the fusion was completed. Glyco-
protein El or E2 specificity of the antibodies was determined
either by Western immunoblot analysis (45) or by nucleotide
sequence analysis of MAb-selected neutralization escape
mutants.
MAbs 31, 49, and 50 were gifts of Alan Schmaljohn and
have been characterized previously (39). Isotyping of all
MAbs listed above was performed either by using a mouse
immunoglobulin subtype identification kit (Boehringer
Mannheim) or by immunodiffusion.
Capture and CAB assays. The capture assay was designed
to maintain virion structure in as near a native state as
possible. MAbs were bound nonspecifically to an enzyme-
linked immunosorbent assay (ELISA) plate, and then virus
was added. The ability of the capturing antibody to bind the
virus was detected with horseradish peroxidase (HRP)-
labeled anti-Sindbis virus hyperimmune ascites fluid
(HMAF). The competitive antibody binding (CAB) assay
was a modified version of the capture assay designed to
evaluate the spatial relationships between determinants of
the virus and has been described previously (30). Briefly, the
competing MAb was adsorbed to the surface of a microtiter
plate to capture freshly purified, native or heated virus.
Additional competing MAb was added to bind the remainder
of the available cognate epitopes. HRP-labeled test MAb
was added. The degree to which binding of the HRP-labeled
MAb was inhibited was determined by comparison with
binding of HRP-labeled test MAb to capture virus that
received no additional competing MAb, measuring optical
density (OD) values. Heated virus was prepared for use in
the capture or CAB assay by diluting freshly grown and
gradient purified SB-RL to a volume of 1 to 1.5 ml in
phosphate-buffered saline (PBS) with 1% donor calf serum
(PBS-1%). The sample was heated for 5 or 10 min at 51°C to
expose transitional epitopes. After heating, the virus was
further diluted to a working volume with PBS-3% ovalbumin
and used in the capture or CAB assay.
ELISA. Virus was placed in the wells of a 96-well micro-
titer plate. The plate was placed at 37°C overnight to allow
the virus solution to evaporate. This procedure disrupts the
virus structure so that inaccessible epitopes become ex-
posed. However, external epitopes remain intact and acces-
sible to antibody binding. Details of the assay have been
described previously (30).
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Selection of MAb neutralization escape mutants. All MAb
neutralization escape mutants were selected from stocks of
SB-RL. Escape mutant 12-1 was isolated by heating an
infected-cell supernatant containing SB-RL (approximately
8 x 108 PFIJ/ml) at 510C for 5 min to expose transitional
epitopes. The stock was diluted to 2.5 x 105 PFU in 0.25 ml
of PBS-1%. A 100-pl aliquot ofMAb R12 ascites fluid and 50
pl of guinea pig serum (as a source of complement; Cedar-
lane) were added to the heated virus stock. The mixture was
incubated at 37°C for 1 h. After incubation, 20 pl of goat
anti-mouse IgG (Sigma), 50 pl of complement, and 30 ,ul of
PBS-1% were added to the virus-MAb R12 mixture to
enhance virus neutralization. The solution was incubated for
1 h at 37°C, and then a 60-mm-diameter tissue culture plate
of BHK-21 cells was infected with 200 pl of the mixture.
Progeny virus-containing culture supernatant was harvested
following the appearance of cytopathic effect. This proce-
dure was repeated three more times to selectively amplify
the variant population, using 10 pl of the culture supernatant
as inoculum for the ensuing round of enrichment. After
amplification, the supernatants were titered in a plaque
assay, and isolated plaques were picked. The agarose plugs
in PBS-1% were seeded directly onto BHK cells in 24-well
tissue culture plates. The supernatants from wells showing
cytopathic effect were assayed for virus capable of escaping
R12 binding in a capture assay. These candidate mutants
were grown and purified. The virus suspensions were evap-
orated to dryness in a microtiter plate, and the lack of
reactivity with R12 was reconfirmed by ELISA. One of the
isolates (RLmcl2-1) was grown again in the presence of
MAb R12 and plaque purified to ensure its genetic purity.
Neutralization escape mutants were isolated with MAbs
R15, R501, R502, R503, R505, R2, and R4, using the same
basic protocol as that used for RLmcl2-1 except that the
starting stock of SB-RL was diluted to 105 PFU in 200 ,ul of
PBS-1% and MAb concentrations were optimized for the
ability to neutralize in the presence of a rabbit anti-mouse
IgG (Sigma). Optimal final dilutions of neutralizing MAb
varied from 1:90 to 1:4,500. MAb and virus were allowed to
incubate for 1 h at 37°C before the addition of 50 ,ul of rabbit
anti-mouse IgG. The mixture was incubated at 37°C for 15
min, 50 pl of complement was added, and the mixture was
further incubated for 45 min at 37°C. Antibody R2 and R4
escape mutants appeared to be less common in the popula-
tion of virus stocks, so dilutions of the collected superna-
tants were not made after their passage under antibody
selection. Amplification of all escape mutants was accom-
plished by repeating this procedure four times.
Escape mutant RLmcl2-19 was isolated by a different
approach. Virus was diluted and heated as described above,
and 50 ,ul of R12 ascites fluid was added. After incubation at
37°C for 1 h, 150 pl of a gold-labeled goat anti-mouse IgG
preparation (13) was added, and the mixture was incubated
for 1 h at 37°C. After incubation, the solution was centri-
fuged at 13,000 rpm for 20 min in a Fisher microcentrifuge.
The supernatants were collected and used to infect mono-
layers of BHK cells in 60-mm-diameter dishes. This process
was repeated three more times to amplify the mutant popu-
lation, using the supernatants from plates displaying cyto-
pathic effect. Plaque-purified isolates of the escape mutants
were obtained and screened for lack of R12 reactivity by the
method described above.
Sequencing the mutants. Sequencing of the glycoprotein
genes of the variants was done by oligonucleotide-primed
dideoxynucleotide chain termination (51) directly on purified
viral or intracellular RNA, using primers and protocols as
detailed by Davis et al. (11).
Intracellular RNA was isolated by the following method.
BHK cells were infected at a multiplicity of infection of 2 to
10. Six hours postinfection, the cells were washed twice with
a hypotonic buffer (3.3 mM NaCl, 0.5 mM MgCl2, 3.3 mM
Tris-HCl [pH 8.5]). The cells were collected in 1 ml of the
buffer by using a rubber policeman and allowed to swell for
10 min before the addition of 0.45% Nonidet P-40. The
mixture was vortexed and then centrifuged at 800 x g to
eliminate nuclei. RNA was extracted from the supernatants
by using phenol-chloroform-isoamyl alcohol. The RNA was
precipitated overnight at -20°C in 2.5 volumes of ethanol
and 0.025 volume of 4 M NaCl.
In vitro mutagenesis. TR5196 and TR5278 were products of
site-directed mutagenesis performed by a modification of the
method of Kunkel et al. (23) in which Klenow fragment
(2,250 U; Promega) was used in place of T4 DNA poly-
merase. An M13 DNA template containing SB-RL E2 se-
quences was used for oligonucleotide-primed mutagenesis.
Restriction endonuclease digestions of the replicative forms
of the plasmids containing the mutagenized E2 genes and of
pTR5000 were performed, and an E2 fragment (StuI nucle-
otide 8571 to BssHII nucleotide 9804) of pTR5000 was
replaced by the mutagenized homologous sequences. The
plasmids were used to transform Escherichia coli JM101,
and transformants were picked and grown. Plasmid DNA
samples were screened by restriction enzyme digestion, the
appropriate plasmid DNA was cut with XhoI, and full-length
Sindbis virus transcripts were produced in vitro from an SP6
transcriptional promoter. The specific infectivities of the
transcripts were shown to be equivalent to that of wild-type
pTR5000 transcripts. Transfection of BHK cells was accom-
plished with Lipofectin (Bethesda Research Laboratories) as
recommended by the manufacturer. TR5196 and TR5278
were recovered from the transfection supernatants. The
genomic RNAs of TR5196 and TR5278 were sequenced to
confirm the base changes at E2 codons 196 and 278, respec-
tively.
RESULTS
Accessibility of Sindbis virus glycoprotein epitopes. The
MAbs used in this study, their isotypes, El or E2 glycopro-
tein specificity, and epitope accessibility, based on previ-
ously published results (13, 28), are summarized in Table 1.
Accessible epitopes are present on the surface of the glyco-
protein spike and allow binding ofMAb to native virus. MAb
binding to inaccessible epitopes is inhibited either because of
steric hindrance at the surface of the glycoprotein as a result
of the size of the MAb molecule or because the tertiary
structure of the glycoprotein places the epitope beneath the
surface of native virions.
The accessibility of an epitope was determined by the
binding pattern of the MAb in two assays. In the first assay,
Sindbis virus was evaporated in wells of an ELISA microti-
ter plate, resulting in partial disruption of virions and expo-
sure of previously inaccessible epitopes, while accessible
epitopes remained intact. Individual MAbs were tested for
the ability to bind disrupted virus as detected by HRP-
labeled goat anti-mouse Ig. In the second assay, MAb was
bound nonspecifically to an ELISA plate, and purified native
SB-RL was added. Virion capture was detected by HRP-
labeled anti-Sindbis virus HMAF. If a MAb bound virus in
both assays, the epitope was considered accessible on the
surface of native virions. If the MAb bound to disrupted
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TABLE 1. Accessibility of Sindbis virus glycoprotein epitopes
Epitope accessibility
MAb Glycoprotein IoyeCellspecificity sotype Native Heated
virionsa surface virionsCvinionsb
R509 E2 IgGl - - -
R512 E2 IgGl - - -
R3 El IgA - NDd +
R4 El IgA - +. +
R500 El IgGl - - +
R510 El IgG2b - - +
3le El IgG2b - +
R9 El IgG2a - +
R2 El IgG2b - + +
R12 E2 IgGl - + +
R501 E2 IgGl - + +
R503 E2 IgG2a - + +
RS05 E2 IgG2a - + +
R6 E2 IgG2a + + +
R8 E2 IgG3 + + +
R10 E2 IgG3 + + +
R15 E2 IgG2a + + +
R502 E2 IgG2a + + +
49e E2 IgG2a + + +
SOe E2 IgG2b + + +
a MAb reactivity with use of freshly grown and gradient-purified Sindbis
virus as antigen in a capture ELISA (13, 28).
b MAB reactivity of Sindbis virus-BHK cell complexes established at 4°C
and then shifted to 37°C for 30 min in the presence of the MAb (13).
c MAb reactivity in a capture ELISA using as antigen freshly grown and
gradient-purified Sindbis virus which had been heated to 51'C for 10 min (28).
d ND, not determined.
Gift of Alan Schmaljohn (39, 40, 44).
virus in ELISA but not to native virus in the capture assay,
the epitope was considered inaccessible on native virions.
Epitopes inaccessible on native virions may be further
subdivided into transitional epitopes, those which become
accessible to their cognate MAb at the cell surface, and
internal epitopes which remain inaccessible to MAb at the
cell surface in virus-cell complexes (13). Heating native
Sindbis virions to 51°C mimicked the exposure of transi-
tional epitopes at the cell surface in that most of the
transitional epitope MAbs bound to heated virus (28).
Topographical mapping of El and E2 antigenic sites on
heated virions. CAB assays have been used previously to
examine the spatial relationships between neutralizing anti-
genic determinants present on the E2 glycoprotein of native
Sindbis virus and SB-RL (11, 30). In the present study, we
wished to explore the spatial relationships among neutraliz-
ing antigenic determinants and the epitopes newly accessible
on freshly purified Sindbis virions that had been heated for
10 min at 51°C. Therefore, heated virions were used in a
CAB assay which sought to maintain virion structure as
much as possible (see Materials and Methods). The assay
judged the spatial proximity of two epitopes by noting the
ability of an unlabeled antibody to inhibit the binding of an
HRP-labeled test antibody.
The results of the CAB assay using Sindbis virus are
summarized in Table 2. The data suggest that at least three
newly accessible determinants reside on the El glycoprotein
at the surface of heated Sindbis virus. Reciprocal competi-
tion was evident for epitopes bound by R3 and R4, and
likewise for R500 and R510. These two sets of epitopes
defined two determinants on the El glycoprotein. The third
El site was defined by MAb R2, which did not compete
strongly or reciprocally for binding with any of the other El
or E2 specific MAbs.
The transitional epitope MAbs R12, R501, R503, and R505
exhibited strong reciprocal competition for binding on
heated Sindbis virus, which suggested that they recognize
the same determinant on the E2 glycoprotein. The antigenic
site defined by these four MAbs has been designated the E2d
determinant. The E2 MAbs which bind to accessible
epitopes on native virus define three immunodominant E2
neutralizing antigenic sites: E2a (MAbs 49 and 50), E2b
(MAbs R8, R10, R15, and R502), and E2c (MAb R6). Each of
these sites is independently mutable in that neutralization
escape mutations selected with an E2a MAb retains reactiv-
ity with E2b and E2c MAbs, for example. However, the E2a
and E2b sites are in close physical proximity to each other,
as judged from reciprocal competition (11, 30) (Table 2).
Little competition was evident between the E2d-specific
TABLE 2. Competitive binding of MAbs on captured Sindbis virions
Capturing/
% Inhibition of HRP-conjugated MAb binding'
competing Glycoprotein El MAb Glycoprotein E2 MAb
MAb
R2 R3 R4 R500 R510 R6 R10 R502 49 R12 R501 R503 R505
R2 10 6 4 7 9 3 1 4 2 2 3 0 1
R3 7 9 9 7 7 0 0 4 7 5 5 2 0
R4 4 10 10 5 10 0 0 3 3 3 1 2 3
RS00 7 6 7 9 8 3 4 6 4 5 5 6 5
R510 4 2 5 8 10 1 2 2 7 5 5 2 0
R6 5 5 3 3 6 10 5 4 5 6 3 2 3
R10 2 4 2 6 8 8 9 9 10 5 3 3 3
R502 2 5 4 7 7 7 9 10 9 7 6 6 5
49 9 4 4 7 8 8 9 9 10 8 8 5 6
R12 4 3 1 5 6 1 1 3 5 10 10 10 10
R501 4 0 9 7 0 1 2 4 2 10 10 10 10
R503 2 3 0 8 9 3 2 5 5 10 10 10 10
R505 1 0 0 8 8 5 4 5 5 10 10 10 10
a Purified heated Sindbis virions were captured by the indicated MAb, excess capturing/competing MAb was added, and then the HRP-conjugated test MAb
was added. Percent inhibition of binding of conjugated MAb was calculated as [I - (OD with competing MAb/OD without competing MAb)] x 100. Values shown
are percent inhibition divided by 10 and rounded to the nearest integer.
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TABLE 3. El and E2 neutralization escape mutants selected by
using transitional and internal epitope MAbs
Amino acid
Virus isolate Codon (parent to changeposition mutant) (parent to
mutant)
RLmcl2-l E2 200 GAG to CAG Glu to Gln
RLmcl2-19 E2 200 GAG to GUG Glu to Val
RLmc5Ol-l2 E2 200 GAG to CAG Glu to Gln
RLmc5Ol-2A E2 200 GAG to GAA Glu to Lys
RLmc5Ol-4 E2 202 AAG to AUG Lys to Met
RLmc5O3-7A E2 202 AAG to AUG Lys to Met
RLmc505-lA E2 200 GAG to GAA Glu to Lys
RLmc5O5-lC E2 200 GAG to CAG Glu to Gln
E2 374 GCU to UCU Ala to Ser
RLmc5O5-12F E2 202 AAG to AUG Lys to Met
RLmc2-7B El 381 AAA to AAU Lys to Asn
RLmc2-1lA El 250 CCA to CCG No Change
El 361 CCA to CUA Pro to Leu
RLmc4-lD El 300 AAA to ACA Lys to Thr
RLmc4-6F El 300 AAA to GAA Lys to Glu
RLmc4-7H El 300 AAA to AUA Lys to Ile
antibodies and the E2a-, E2b-, or E2c-specific MAbs on
heated Sindbis virus particles.
These data, in conjunction with those previously obtained
in parallel experiments with native virus, suggest that the
rearrangement induced by heating the virions was subtle.
The spatial relationship between the three neutralizing anti-
genic sites, E2a, E2b, and E2c, on heated virions was
virtually identical to that observed on native Sindbis virus
particles (11, 30).
Selection of MAb neutralization escape mutants. To map
transitional epitopes to specific amino acid sequences on El
and E2, we took advantage of the observation that heated
virions retained infectivity, that they displayed a subset of
the transitional epitopes, and that their infectivity could be
neutralized by the cognate transitional epitope MAbs. This
allowed the selection of MAb escape mutants, the genomes
of which could be sequenced to map putative amino acid
constituents of the transitional epitopes. SB-RL was used in
these selections, because this strain grew to higher titers
than did its parent, AR339, and because neutralization with
certain MAbs was more efficient with SB-RL (29).
Two approaches employing a second antibody to enhance
neutralization were used to isolate the escape mutants. In
both cases, the primary MAb was reacted with heated
SB-RL virions to establish virus-MAb complexes. One ap-
proach used the addition of gold-labeled goat anti-mouse IgG
as a second antibody, followed by centrifugation to pellet
heated virus-MAb complexes (see Materials and Methods).
Another, more traditional approach used either a rabbit
anti-mouse IgG or goat anti-mouse IgG as second antibody
and complement to aid neutralization of the heated virus-
MAb complexes. Multiple growth cycles in BHK cells under
MAb pressure were used in all cases to select against
wild-type particles that might have outgrown a mutant
during the amplification of the escape mutant population.
Plaque isolates were grown on BHK cells, heated, and
screened in both a capture and a conventional ELISA for
lack of binding to the selecting MAb. Mutants having signif-
icantly reduced binding activity were selected for sequenc-
ing. None of the mutants lost the ability to bind MAbs to the
three E2 neutralizing antigenic sites.
The El and E2 glycoprotein genes of the escape mutants
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FIG. 1. Single-step escape mutants in the major E2 neutraliza-
tion domain. The schematic diagram shows the structural features of
the region including E2a and E2b neutralization sites, the glycosy-
lation site at E2 Asn-196, and the E2d transitional epitope at amino
acid positions 200 and 202. Letters at the bottom represent the E2
amino acid sequence of Sindbis virus AR339. The symbols represent
each of the three immunodominant E2 neutralization sites defined
by reciprocal MAb competition and patterns of reactivity of neu-
tralization escape mutants (0, E2a; l, E2b; O, E2 transitional). The
letters within the symbols are amino acid substitutions identified
among single-step neutralization escape mutants. Mutants E2 Ile-
216, E2 Pro-214, and E2 Met-190 were reported by Strauss et al.
(44). The remaining mutants were reported by Davis et al. (11) and
in this report.
were sequenced, and Table 3 shows a compilation of the data
for representative isolates. All of the E2 variants, whether
selected with R12, R501, R503, or R505, had mutations at
either E2 amino acid position 200 or E2 amino acid position
202. Also, each of the mutations, regardless of the selecting
MAb, significantly reduced binding to all four of these
MAbs. At E2 codon 200, a single base change could theo-
retically give seven amino acid substitutions for the wild-
type glutamic acid. Three of these, glutamine, lysine, and
valine, were represented among the mutants. The double
mutant RLmc5O5-lC had amino acid substitutions at posi-
tions 200 and 374. The change at 374 was seemingly conser-
vative (serine substituted for wild-type alanine) and occurred
in the E2 transmembrane region (17, 33). At E2 amino acid
202, only methionine substitutions for the wild-type lysine
were recorded among the several variants sequenced.
The mutants isolated by using El-specific MAb R4 all had
amino acid substitutions at position 300. The wild-type
lysine was changed to a threonine, glutamic acid, or isoleu-
cine at this position. R2 escape mutants were isolated with
coding changes at either El 361 or El 381, which substituted
leucine and asparagine for wild-type proline and lysine,
respectively. Since the R2 escape mutations map 20 residues
apart on the primary sequence, this epitope may be confor-
mational. Several attempts were made to isolate escape
mutants with MAbs R500 and R510. Although these antibod-
ies strongly neutralized heated virions, no escape mutants
were recovered. The El glycoprotein contains several re-
gions which are highly conserved among the alphaviruses. If
MAbs R500 and R510 recognize epitopes which consist of
such conserved domains, then it is possible that any muta-
tion which would allow escape from MAb neutralization also
would be lethal.
Role of the complex N-linked oligosaccharide at E2 amino
acid 196 in the accessibility of the E2d determinant. Two
predicted N-linked glycosylation sites, Asn-X-Thr, are uti-
lized on the E2 glycoprotein of Sindbis at amino acid
positions 196 and 318 (20, 27, 35). The proximity of the
complex carbohydrate moiety at residue 196 to the E2
200-202 region raised the possibility that antibody binding to
the E2d determinant on native virus was occluded by the
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TABLE 4. Accessibility of transitional epitopes on
TR5000 and TR5196
Epitope accessibility
MAb Standard ELISAM Capture ELISA"
TR5000 TR5196 TR5000 Heated TR5196 HeatedTR5000 T5 TR5196
49 100 100 100 88 100 31
R12 93 93 32 420 (13) 21 90 (4)
R501 103 104 20 300 (15) 6 48 (8)
R503 97 104 8 284 (36) 6 60 (10)
R505 99 99 16 284 (18) 13 54 (4)
a TR5000 and TR5196 were assayed under standard ELISA conditions (Ma-
terials and Methods), which partially disrupt virion structure and expose transi-
tional and internal epitopes. The testMAbwas added, and then HRP-labeled goat
anti-mouse IgG was added. OD values (0.04) obtained with a nonspecific MAb
(MAb 5806, specific for the tobacco etch virus 58K protein [43]) were deducted
from the OD values obtained with the test MAbs (ranging from 0.67 to 0.81) and
then were normalized by setting the MAb 49 value to 100%.
b In the capture assay, the indicated MAb was adsorbed to an ELISA plate,
and then either fresh native virus or virus that had been heated for 5 min at
51°C was added. Captured virions were detected with HRP-labeled anti-
Sindbis virus HMAF. OD values (ranging from 0.01 to 0.07) obtained with the
nonspecific control MAb 5806 were deducted from the OD values obtained
with the test MAbs (ranging from 0.03 to 1.10) and then were normalized by
setting the MAb 49 value to 100%. Fold increase over the level for unheated,
native virions is given in parentheses.
site-directed mutagenesis was used to substitute a glutamine
codon (CAG) for the wild-type asparagine codon (AAC) at
residue 196. TR5196 was gradient purified, and the migration
pattern of its viral proteins was compared by SDS-polyacryl-
amide gel electrophoresis with the parental TR5000 pattern.
Without the carbohydrate moiety, PE2 (the precursor of E2)
and E2 proteins of TR5196 migrated faster than the corre-
sponding proteins of TR5000 (data not shown).
TR5196 was compared with TR5000 in an ELISA and in a
capture assay (Table 4). In these experiments, MAb 49,
specific for an external neutralization epitope, E2a, func-
tioned as the positive control capable of binding TR5196 or
TR5000 virions, and MAb 5806, specific for the putative
RNA polymerase of tobacco etch virus (43), served as the
negative control. The ELISA data indicated that neither the
carbohydrate moiety nor the amino acid (glutamine) at
position 196 was part of the E2d antigenic site, since
disrupted TR5196 and TR5000 bound equivalent amounts of
each MAb. In the capture assay, the two virus strains
showed similar binding patterns. MAbs R12, R501, R503,
and R505, which were specific for E2d transitional epitopes,
did not efficiently capture native TR5196 or TR5000. Upon
heating of the two virus strains at 51°C, the E2d epitopes
became exposed, as reflected by the increased amount of
TR5196 or TR5000 captured. These data indicate that the
oligosaccharide present at E2 196 did not contribute to the
inaccessibility of the E2d determinant on native virus.
Although neither the amino acid at position 196 nor the
oligosaccharide appeared to be within the E2d determinant,
it was noted that compared with heated TR5000, less heated
TR5196 was captured by MAbs R12, R501, R503, and R505
(Table 4). This result may reflect a structural difference
between the two strains as a result of the replacement of the
wild-type residue at E2 196 or the lack of a carbohydrate
moiety at this position.
E2b MAb escape mutations. Another feature of the E2
glycoprotein in close proximity to the transitional E2d site at
E2 200 to 202 is the E2b neutralization site (Fig. 1). Davis et
al. (11) mapped a major determinant of the E2b neutralizing
antigenic site to E2 residue 216 by analyzing the sequences
and MAb reactivity patterns of several laboratory strains of
Sindbis virus as well as MAb R8 neutralization escape
mutants. Similar results were obtained by Strauss et al. (44),
who examined escape mutants selected with single or mul-
tiple MAbs and revertants of such mutants which had
regained E2b reactivity. To determine the extent of the E2b
site, additional escape mutants have been selected with two
other MAbs, R15 and R502, which were tentatively mapped
to the E2b site on the basis of competition for binding with
other E2b MAbs (data not shown).
Table 5 shows the reactivities of previously isolated R8
(E2b)-selected neutralization escape mutants with MAbs
R15 and R502. MAbs R15 and R502 both bound to an R8
mutant (RLmc8-1) having a Glu-to-Val change at E2 216, but
binding of R502 was somewhat reduced with an E2 Gly-216
TABLE 5. Reactivities of R8-, R15-, and R502-selected variants with E2a, E2b, and E2c MAbs in ELISAW
ELISA result" with MAb:
Virus isolate MAbdilution 49 50 R8 R10 R6 R15 R502
(E2a) (E2a) (E2b) (E2b) (E2c) (E2b) (E2b)
SB-RL (Gly-209, Thr-213, Glu-216, His-278) 100 100 100 100 100 100 100
RLmc8-1 (Val-216)C 10-2 174 128 5 ND 114 88 84
RLmc8-3 (Gly-216) 10-2 138 107 7 ND 85 77 41
RLmc8-c (Asn-213) 10-2 104 76 11 ND 81 100 34
10-3 70 106 8 0 163 34 8
RLmcl5-2 (Glu-209) 10-3 87 84 6 1 108 79 13
10-4 ND ND ND ND ND 29 ND
RLmc5O2-a (Arg-209) 10-2 118 106 87 141 112 50 14
RLmc5O2-b (Arg-209, Asn-213) 10-2 3 90 6 0 126 52 9
10-3 0 46 5 0 80 ND 0
RLmc502-c (Asn-213, Tyr-278) 10-2 4 91 6 1 114 53 14
10-3 0 23 0 ND 85 ND 0
TR5278 (Tyr-278)d 10- 94 95 89 ND 104 100 105
a Gradient-purified viruses were adsorbed to microtiter wells by evaporation, and 50 al of ascites fluids containing MAb, diluted as indicated in PBS, was added.
Bound primary MAb was detected with HRP-labeled goat anti-mouse IgG.
b ELISA results were normalized by comparing the OD values obtained for the variants with that for the SB-RL control. The results are presented as a
percentage of the SB-RL control level. ND, not determined.
c Variants were isolated by selection with the indicated MAb as described in Materials and Methods.
d Site-directed mutant in the pTR5000 clone as described in Materials and Methods.
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mutant (RLmc8-3). Whereas E2 216 is the major determinant
of the reactivity of E2b MAbs R8, R10 (11), 18, and 23 (44),
it appeared that this residue was at the periphery of the R15
and R502 epitopes. In another R8-selected mutant (RLmc8-
c), E2 Thr-213 was replaced with Asn, which was used as a
site for N-linked glycosylation (11). This mutation and/or its
attendant carbohydrate moiety strongly affected binding to
R8, R10, R15, and R502. Little or no effect on E2a MAb
reactivity (MAbs 49 and 50) was observed with either the E2
216 or E2 213 mutation. In the case of the E2 213 mutation,
this was somewhat surprising, since a MAb 49 escape
mutant had been mapped previously to E2 214 (44).
Also shown in Table 5 are the E2 mutations found in the
genomes of neutralization escape mutants selected with R15
and R502 as well as the MAb reactivities of these mutants.
These MAbs selected for single mutants at E2 209: Gly to
Glu (RLmcl5-2) orArg (RLmcl5-4 and RLmc5O2-a). The E2
Glu-209 substitution reduced binding of R8, R10, R15, and
R502, whereas the E2 Arg-209 substitution preferentially
affected R15 and R502 binding. These data in conjunction
with the reactivity patterns of R15 and R502 with R8-
selected mutants suggested that the E2b neutralization site
contains at least two overlapping epitopes which span E2
residues 209 to 216.
Two double mutants also were among those selected by
R502, one with Gly to Arg at E2 209 and Thr to Asn at E2 213
and the other with Thr to Asn at E2 213 and His to Tyr at E2
278. As expected of mutants containing the N-linked glyco-
sylation site at E2 213, these double mutations caused
reduced binding of E2b MAbs R8, R10, R15, and R502.
Unlike the single mutants at E2 213, however, the double
mutants also affected the binding of the E2a MAbs, abrogat-
ing binding of MAb 49 and reducing binding of MAb 50.
Neither E2 Arg-209 nor E2 Tyr-278, as a single mutation (in
escape mutant RLmc502-a and site-directed mutant TR5278,
respectively), affected binding of either of the E2a MAbs.
DISCUSSION
Virus structure must be stable in the extracellular envi-
ronment to prevent the degradation of its genetic material,
yet the virus must uncoat to replicate. The shift from a stable
to a disassembled form occurs early in infection. Disassem-
bly of some viruses begins before the particle traverses the
plasma membrane and can involve a series of structural
intermediates rather than a single uncoating event. Confor-
mational alterations in the structure of viral proteins during
the early events of infection have been documented for T2
and T4 bacteriophage (3, 41) and several animal viruses such
as reovirus (6, 16), influenza virus (4), and picornaviruses
(10, 14, 24, 25). In the case of poliovirus, conformational
rearrangements in virions which occur at the plasma mem-
brane (14) can be reproduced in vitro by interaction with a
soluble form of the poliovirus receptor (21).
We have demonstrated that a conformational rearrange-
ment of the Sindbis virus glycoprotein spike can be detected
as newly accessible El and E2 transitional epitopes at the
plasma membrane after attachment but prior to entry of
virions (13). In this study, we have mapped some of these
transitional epitopes by using heated virions as a model for
the structural intermediate detected at the cell surface.
Although the heat-induced rearrangement of Sindbis virus is
not identical to that observed on virus-cell complexes, the
patterns of epitope exposition are similar (28). Compared
with other means of artificially inducing a structural rear-
rangement, such as treatment with dithiothreitol or low pH,
the heated virions more faithfully reproduce the constella-
tion of accessible epitopes found on the authentic cell
surface intermediate. The heated virions retained their in-
fectivity and could be neutralized by transitional epitope
MAbs, making it possible to map the transitional epitopes by
selection of MAb escape mutants and sequencing their
glycoprotein genes.
The transitional epitope bound by MAb R2 appeared to be
conformational, because it mapped to two amino acids (El
positions 361 and 381) separated by 20 amino acids on the
linear peptide sequence. Both amino acid changes lie adja-
cent to short alphavirus conserved amino acid regions (five
and seven amino acids, respectively). These residues may be
located near the base of the glycoprotein spike, as they are
close to the transmembrane region. Hydrophobicity analysis
indicated that El 361 and 381 reside in hydrophilic regions
(data not shown), suggesting that this epitope would be an
exposed domain on isolated El glycoprotein molecules.
Therefore, in the context of the native glycoprotein spike, this
domain may be occluded by the association of El and E2 into
heterodimers (36), by the association of heterodimers into
trimers (15, 31, 36,46), or by other El interactions involved in
stabilization of the virion surface architecture (2).
The epitope recognized by MAb R4 is inaccessible on
native virions, is inconsistently exposed at the cell surface,
but is accessible on heated virions. MAb R4 has an IgA
isotype so that the structural requirements for accessibility
of the R4 epitope may be considerably different than would
be the case if accessibility of the same epitope could be
assayed with an IgG isotype MAb. The population of MAb
R4 neutralization escape mutants contained three different
amino acid substitutions at El 300. This residue is in the
vicinity of El 313, at which mutation alters the pH require-
ments for cell-cell fusion by Sindbis virus (7).
Competition binding assays on heated virus suggested that
all of the identified E2 transitional epitopes resided within a
single antigenic site which we have termed E2d. Of nine
independently isolated mutants selected by the four E2
transitional epitope MAbs, all contained mutations at either
E2 200 or E2 202. This region of the E2 glycoprotein (Fig. 1)
contains an N-linked glycosylation site (35), two of the
Sindbis virus immunodominant neutralizing antigenic sites
(E2a and E2b) (11, 44), and a putative virion site for binding
a Sindbis virus receptor on chicken embryo fibroblasts
(CEF) (48).
Removal of the N-linked carbohydrate at E2 196 by
site-directed mutagenesis did not relieve the inaccessibility
of the E2d site on native virions, nor did it alter the exposure
of the E2d site on heated particles. This result suggests that
the arrangement of the spike rather than glycosylation is the
primary determinant of E2d accessibility.
Analysis of E2a and E2b escape mutants indicates that
these two sites are mutationally independent; E2b MAbs
bind E2a escape mutants and vice versa. However, the
locations of the mutations involved (E2a, 190 and 214; E2b,
209, 213, and 216) indicate that the two sites overlap on the
primary amino acid sequence of the glycoprotein. Strong
reciprocal competition between E2a and E2b MAbs, ob-
served in CAB assays on intact virions, supports this inter-
pretation and suggests that the two sites are in very close
proximity in the native structure (11, 30). Surprisingly, the
configuration of the E2a and E2b sites was not detectably
changed on heated particles, while the E2d site, which
mapped between E2a and E2b, became accessible to MAb.
Also unexpected was the low level of reciprocal competition
between the E2d MAbs and MAbs to the E2a and E2b sites.
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One interpretation of these results is that the mutations at E2
200 to 202 allosterically affect E2d MAb binding, with the
actual E2d site being located elsewhere on E2. While this
possibility cannot be excluded, it seems unlikely that all of
the escape mutations would fall in an allosterically active site
but none would be in the actual epitope of nine different
mutants selected with four different MAbs. We favor a
second interpretation, that E2a and E2b MAbs bind on the
same face of the three-dimensional E2 glycoprotein, one that
is accessible to antibody in the native virion. The E2d site,
although between E2a and E2b on the primary sequence,
may lie on another face of the glycoprotein which is acces-
sible to antibody only after structural rearrangement of the
spike.
A putative Sindbis virus receptor was identified on CEF
by using an anti-idiotypic antibody raised against E2a MAb
49 (48). The inferences are that the MAb 49 epitope consti-
tutes the virion site which interacts with the CEF receptor
and that E2 transitional epitopes are adjacent to it. However,
BHK cells and CEF apparently do not share the same
receptor (47, 48), so it remains unclear what relevance the
CEF receptor binding site has to rearrangements induced by
binding to the BHK receptor. It will be interesting to
examine virion rearrangements induced by binding to CEF
and to determine the ability of the E2d mutants to infect
CEF.
The functional role of domains exposed following confor-
mational rearrangement of infecting virions at the plasma
membrane is not known, nor is it known whether the
transitional epitopes identified in this report are themselves
constituents of functional domains. The transitional epitopes
may represent markers of the rearrangement, while putative
function resides in other newly exposed domains not reac-
tive with the available panel of MAbs. We hypothesize that
the initial attachment step itself, and/or the microenviron-
ment at the cell surface (8, 26), triggers the conformational
rearrangement and that domains newly accessible after the
rearrangement function in a second-stage interaction with an
element(s) of the plasma membrane. Such a two-stage at-
tachment sequence is compatible with the classical concept
of an initial reversible binding of virus to cell followed by an
irreversible tight binding. The second-stage interaction could
catalyze direct fusion of the viral envelope with the plasma
membrane either with or without subsequent rearrange-
ments induced by the reductive environment at the cell
surface (1). Alternatively, the postulated second-stage inter-
action could initiate receptor-mediated endocytosis. In the
latter case, additional conformational changes could be
induced by the low-pH environment of the endosome, lead-
ing to fusion with the endosomal membrane. Although our
results do not distinguish between these models for subse-
quent steps in the disassembly pathway, they strongly sug-
gest that the first step in the disassembly of Sindbis virus
occurs at the cell surface and is characterized by the
exposure of specific, previously inaccessible glycoprotein
domains.
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